222 related articles for article (PubMed ID: 15635544)
1. Immunosuppression, diagnosis, and treatment of cardiac allograft rejection.
Patel JK; Kobashigawa JA
Semin Thorac Cardiovasc Surg; 2004; 16(4):378-85. PubMed ID: 15635544
[TBL] [Abstract][Full Text] [Related]
2. Cardiac allograft rejection.
Patel JK; Kittleson M; Kobashigawa JA
Surgeon; 2011 Jun; 9(3):160-7. PubMed ID: 21550522
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppression for heart transplantation: where are we now?
Kobashigawa JA; Patel JK
Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):203-12. PubMed ID: 16568129
[TBL] [Abstract][Full Text] [Related]
4. Minimization of immunosuppression: transplant immunology.
Patel J; Kobashigawa JA
Transpl Immunol; 2008 Nov; 20(1-2):48-54. PubMed ID: 18930138
[TBL] [Abstract][Full Text] [Related]
5. The challenge of rejection and cardiac allograft vasculopathy.
Cotts WG; Johnson MR
Heart Fail Rev; 2001 Sep; 6(3):227-40. PubMed ID: 11391041
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive approaches for the diagnosis of acute cardiac allograft rejection.
Miller CA; Fildes JE; Ray SG; Doran H; Yonan N; Williams SG; Schmitt M
Heart; 2013 Apr; 99(7):445-53. PubMed ID: 23257172
[TBL] [Abstract][Full Text] [Related]
7. Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients.
Itescu S; Burke E; Lietz K; John R; Mancini D; Michler R; Rose E; Oz M; Edwards N
Circulation; 2002 Mar; 105(10):1214-9. PubMed ID: 11889016
[TBL] [Abstract][Full Text] [Related]
8. Biopsy-negative cardiac transplant rejection: etiology, diagnosis, and therapy.
Fishbein MC; Kobashigawa J
Curr Opin Cardiol; 2004 Mar; 19(2):166-9. PubMed ID: 15075746
[TBL] [Abstract][Full Text] [Related]
9. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
[TBL] [Abstract][Full Text] [Related]
10. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
[TBL] [Abstract][Full Text] [Related]
11. Prevention and treatment of severe hemodynamic compromise in pediatric heart transplant patients.
Costello JM; Pahl E
Paediatr Drugs; 2002; 4(11):705-15. PubMed ID: 12390042
[TBL] [Abstract][Full Text] [Related]
12. Imaging in Heart Transplant Patients.
Olymbios M; Kwiecinski J; Berman DS; Kobashigawa JA
JACC Cardiovasc Imaging; 2018 Oct; 11(10):1514-1530. PubMed ID: 30286911
[TBL] [Abstract][Full Text] [Related]
13. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
14. Is biopsy-proven cellular rejection an important clinical consideration in heart transplantation?
Kirklin JK
Curr Opin Cardiol; 2005 Mar; 20(2):127-31. PubMed ID: 15711199
[TBL] [Abstract][Full Text] [Related]
15. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
[TBL] [Abstract][Full Text] [Related]
16. Immune function surveillance: association with rejection, infection and cardiac allograft vasculopathy.
Heikal NM; Bader FM; Martins TB; Pavlov IY; Wilson AR; Barakat M; Stehlik J; Kfoury AG; Gilbert EM; Delgado JC; Hill HR
Transplant Proc; 2013; 45(1):376-82. PubMed ID: 23267802
[TBL] [Abstract][Full Text] [Related]
17. Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes.
Kobashigawa JA; Kiyosaki KK; Patel JK; Kittleson MM; Kubak BM; Davis SN; Kawano MA; Ardehali AA
J Heart Lung Transplant; 2010 May; 29(5):504-8. PubMed ID: 20133166
[TBL] [Abstract][Full Text] [Related]
18. Severe cardiac allograft dysfunction without endomyocardial biopsy signs of cellular rejection: incidence and management.
Veiga Barreiro A; Crespo Leiro M; Doménech García N; Paniagua MJ; Vázquez Martul E; González Cuesta M; Ramírez C; Juffé Stein A; Castro Beiras A
Transplant Proc; 2004 Apr; 36(3):778-9. PubMed ID: 15110660
[TBL] [Abstract][Full Text] [Related]
19. Role of humoral immunity in acute cardiac allograft dysfunction.
Costanzo-Nordin MR; Heroux AL; Radvany R; Koch D; Robinson JA
J Heart Lung Transplant; 1993; 12(2):S143-6. PubMed ID: 8476884
[TBL] [Abstract][Full Text] [Related]
20. Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility.
Costanzo-Nordin MR
J Heart Lung Transplant; 1992; 11(3 Pt 2):S90-103. PubMed ID: 1623009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
